Learning and knowledge sharing are fundamental to the LHSS Project. We invite you to search LHSS knowledge products and resources for the latest approaches, insights, and learning in the field of integrated health systems strengthening.
With LHSS support, the Government of the Republic of Kazakhstan hosted an Interagency Technical Working Group Coordination Meeting in Astana. Ministries of Health, Veterinary Services, Agriculture, and Ecology, alongside international organizations, discussed collaborative preparedness, human resource capacity for One Health, and joint disease investigation.
Clients at an HIV clinic in Vietnam are finally having their viral load tests reimbursed, thanks to some multisectoral problem-solving facilitated by LHSS.
Vietnam is one of the 30 countries with the highest burden of TB and drug-resistant TB in the world, with more than 172,000 cases and 10,400 deaths from TB in Vietnam in 2020 (WHO). On July 1, TB treatment facilities nationwide started providing TB drugs to patients through social health insurance, marking an important milestone for financial sustainability.
By now, much has been written about the egregious global inequities in COVID-19 vaccine distribution. But less has been said about another inequity that holds serious implications for global health: the disparities in genomic sequencing capacities and capabilities worldwide.
The events of the past 18 months underscore the importance of generally strong, equitable, and accessible health systems. COVID-19 is not the only threat we face, and as we prepare for the future it is critical that we begin to sufficiently invest in the foundational health system strengthening required to develop lasting resilience.
Effort to strengthen Vietnam’s social health insurance program will benefit people with HIV.
Ceremony marked the formal start of the LHSS Project’s four-year effort to help the Government of Vietnam implement its social health insurance program.
LHSS is supporting the capacity development of Vietnam’s National Tuberculosis Program to manage, quantify, procure, and distribute TB first-line drugs through a self-funded health finance system.